During the J.P. Morgan Healthcare Conference, Managing Director Michael Rome shared his thoughts on why biotech in China is ...

We recently compiled a list of the 15 Best Cheap Stocks to Buy for 2025. In this article, we are going to take a look at ...

Another, newer type of cholesterol drug is called PCSK9 inhibitors. These medications work differently by clearing cholesterol already stored in the body’s cells. While both types are effective ...

Pharmacy benefits manager CVS Health has warned that the new PCSK9 inhibitor class of cholesterol-lowering drugs poses an unprecedented challenge to the US healthcare system. In a blog post ...

Alonso has received honoraria fees by participating in an advisory board and symposia for Tecnofarma and Sanofi. Mata has received a research grant from Amryt Pharma Plc. The other authors have ...

When it comes to medications, a new class of drugs called PCSK9 inhibitors is transforming the treatment of high cholesterol, a major risk factor for heart disease. These drugs work by targeting a ...

From the Department of Cardiology and Angiology I, University Heart Center Freiburg, Germany (D.W.) Faculty of Medicine, University of Freiburg, Germany (D.W.) K. Ley has received research funding for ...

PCSK9 Inhibitors Companies are Sirnaomics, Vaxxinity, Verve Therapeutics, Xinlitai Biotechnology, Novo Nordisk, AstraZeneca, Akeso Biopharma, Amgen, Jiangsu Hengrui ...

These regimens significantly reduce low-density lipoprotein cholesterol (LDL-C) levels by nearly 70% and lower lipoprotein a [Lp(a)] by nearly 50%. As the first domestic PCSK9 inhibitor in the NRDL, ...

PCSK9 binds to the LDL receptor/LDL particle complex and prevents LDL receptor recycling. Because PCSK9 mediates premature LDL receptor degradation in the liver, inhibition of PCSK9 activity by ...